Delivery Order SPE2DB20D3101-SPE2DB23FRNY7
Award Date
6/9/23
Potential Completion Date
7/3/23
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,144.94 delivery order contract is for the supply of Ingrezza 80 mg capsules, a medication used to treat a neurological condition. The contract has a completion date of July 24, 2023 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ingrezza 40 mg capsules. The contract, valued at $6,239.10, is a firm fixed-price delivery order with an ultimate completion date of April 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 firm fixed-price delivery order is for Ingrezza 80 mg capsules, a specialty medication. The contract has an ultimate completion date of January 14, 2025 and was awarded on December 20, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.31 firm fixed-price delivery order is for the provision of Ingrezza 40 mg capsules, a medication used to treat a neurological disorder. This award is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $3,893.15, is for the delivery of Ingrezza 80 mg capsules. The award is a delivery order contract with a firm fixed price pricing type, and an ultimate completion date of June 14, 2024. This contract appears to be part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.98 Firm Fixed Price Delivery Order is for the supply of 4557322560 - Ingrezza 80 mg capsules, a medication used to treat a rare movement disorder. The contract has an ultimate completion date of June 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,022 firm-fixed price delivery order covers the supply of Ingrezza 60 mg capsules, a specialty medication, to support federal healthcare programs. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ingrezza 40 mg capsules to the U.S. government. The contract, valued at $10,659.93, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for pharmaceutical products and medical supplies. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical and a $750,000 IDC with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the provision of pharmaceutical products, including Ingrezza 80 mg capsules, to support the Department of Defense (DoD) and other government agencies. The award, valued at $7,786.30, is a Delivery Order contract with a firm fixed price. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Ingrezza 80 mg capsules. The $3,893.15 firm fixed-price delivery order has a completion date of November 8, 2024. The contract is not associated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...